Hypofractionation is a proven safe and effective modality for postoperative whole-breast radiotherapy for early breast cancer patients

Medical Physics

Volumn 36, Issue 6, 2009, Pages 1927-1930

  Brown, Stephen L ^a   Rodger, Alan ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST RADIOTHERAPY; EARLY BREAST CANCER; HYPOFRACTIONATION;

RADIOSENSITIZING AGENT;

BRACHYTHERAPY; BREAST CANCER; CANADA; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; EVIDENCE BASED PRACTICE; HUMAN; HYPOFRACTIONATION; HYPOXIA; IRRADIATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION; RADIATION ABSORPTION; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; REOXYGENATION; REVIEW; SAFETY; TUMOR GROWTH; UNITED KINGDOM; WHOLE BREAST IRRADIATION; ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; METHODOLOGY; RADIATION INJURY; RADIATION PROTECTION;

BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; POSTOPERATIVE CARE; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL;

EID: 66449135964     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3116462     Document Type: Review

References (19)

1. B. Kavanagh, " Clinical experience shows that catastrophic late effects associated with ablative fractionation can be avoided by technological innovation.," Semin. Radiat. Oncol. 1053-4296 18, 223-228 (2008). 10.1016/j.semradonc.2008.04.002
2. T. Whelan, " Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node negative breast cancer.," Breast Cancer Res. Treat. 0167-6806 106, S6 (2007).
3. J. R. Owen, " Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial.," Lancet Oncol. 1470-2045 7, 467-471 (2006). 10.1016/S1470-2045(06)70699-4
4. M. Story, R. Kodym, and D. Saha, " Exploring the possibility of unique molecular, biological, and tissue effects with hypofractionated radiotherapy.," Semin. Radiat. Oncol. 1053-4296 18, 244-248 (2008). 10.1016/j.semradonc.2008.04.006
5. T. J. Whelan, D. H. Kim, and J. Sussman, " Clinical experience using hypofractionated radiation schedules in breast cancer.," Semin. Radiat. Oncol. 1053-4296 18, 257-264 (2008). 10.1016/j.semradonc.2008.04.008
6. Y. Yamada, " High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 71, 484-490 (2008). 10.1016/j.ijrobp. 2007.11.046
7. F. Baillet, M. Housset, D. Dessard-Diana, and G. Boisserie, " Positive clinical experience with misonidazole in brachytherapy and external radiotherapy.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 16, 1073-1075 (1989). (Pubitemid 19154305)
8. M. I. Koukourakis, " Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): A new concept in radiotherapy and encouraging results in breast cancer.," Semin. Oncol. 0093-7754 29, 42-46 (2002). 10.1053/sonc.2002.37359
9. The START Trialists' Group, " The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.," Lancet 0140-6736 371, 1098-1107 (2008). 10.1016/S0140-6736(08)60348-7
10. T. D. Bates, " The 10-year results of a prospective trial of post-operative radiotherapy delivered in 3 fractions per week versus 2 fractions per week in breast carcinoma.," Br. J. Radiol. 0007-1285 61, 625-630 (1988). (Pubitemid 18164702)
11. A. Rodger, W. J. L. Jack, and G. Kerr, " A change in post mastectomy radiotherapy fractionation: An audit of tumour control, acute and late morbidity.," The Breast 10.1016/S0960-9776(96)90018-1 0960-9776 5, 244-250 (1996).
12. The START Trialists' Group, " The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial.," Lancet Oncol. 1470-2045 9, 331-341 (2008). 10.1016/S1470-2045(08)70077-9
13. T. Whelan, " Randomised trial of breast cancer irradiation schedules after lumpectomy for women with lymph node-negative breast cancer.," J. Natl. Cancer Inst. 0027-8874 94, 1145-1150 (2002).
14. Early Breast Cancer Trialists' Collaborative Group, " Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials.," Lancet 0140-6736 355, 1757-1770 (2000). 10.1016/S0140-6736(00)02263-7
15. P. Canney and A. Alhasso (personal communication).
16. Dictionary of Cancer Terms, National Cancer Institutes, National Institutes of Health (http://www.cancer.gov/Templates/db-alpha.aspx?CdrID= 562081).
17. T. J. Whelan, J. Pignol, J. Julian, L. Grimard, J. Bowen, F. Perera, K. Schneider, W. Shelley, A. Fyles, and M. Levine, " Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node-negative breast cancer.," Int. J. Radiat. Oncol., Biol., Phys. 0360-3016 72, S28 (2008). 10.1016/j.ijrobp.2008.06.829
18. S. O. Freytag, B. Movsas, I. Aref, H. Stricker, J. Peabody, J. Pegg, Y. Zhang, K. N. Barton, S. L. Brown, M. Lu, A. Savera, and J. H. Kim, " Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer.," Mol. Ther. 15, 1016-1023 (2007). 10.1038/mt.sj.6300120 1525-0016
19. Medical Countermeasures Against Radiological and Nuclear Threats website, National Institute of Allergy and Infectious Diseases, National Institutes of Health (http://www3.niaid.nih.gov/topics/radnuc).